Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
Diletta Magini, Cinzia Giovani, Simona Mangiavacchi, et al.
PLoS ONE (2016) Vol. 11, Iss. 8, pp. e0161193-e0161193
Open Access | Times Cited: 119

Showing 26-50 of 119 citing articles:

Perspectives on RNA Vaccine Candidates for COVID-19
Pobitra Borah, Pran Kishore Deb, Nizar A. Al‐Shar’i, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 56
mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases
Ting Le, Chao Sun, Jitao Chang, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 401-401
Open Access | Times Cited: 56
mRNA vaccines: Past, present, future
Mia Karam, Georges Daoud
Asian Journal of Pharmaceutical Sciences (2022) Vol. 17, Iss. 4, pp. 491-522
Open Access | Times Cited: 55
Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
Sean C. Semple, Robert D. Leone, Christopher Barbosa, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 398-398
Open Access | Times Cited: 54
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity
Séan Mc Cafferty, A.K.M. Ashiqul Haque, Aster Vandierendonck, et al.
Molecular Therapy (2022) Vol. 30, Iss. 9, pp. 2968-2983
Open Access | Times Cited: 42
Rise of the RNA machines – self-amplification in mRNA vaccine design
Jerôme D.G. Comes, Gorben P. Pijlman, Tessy A. H. Hick
Trends in biotechnology (2023) Vol. 41, Iss. 11, pp. 1417-1429
Open Access | Times Cited: 40
Self-Amplifying RNA Approach for Protein Replacement Therapy
Dimitri Papukashvili, Nino Rcheulishvili, Cong Liu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12884-12884
Open Access | Times Cited: 38
Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development
Christin Schmidt, Barbara S. Schnierle
Pathogens (2023) Vol. 12, Iss. 1, pp. 138-138
Open Access | Times Cited: 38
Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines
Caryn Myn Li Lim, Thamil Vaani Komarasamy, Nur Amelia Azreen Adnan, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 3
Open Access | Times Cited: 13
Advanced nanoscale delivery systems for mRNA-based vaccines
Maha W. Mobasher, Rais A. Ansari, Ana M. Castejón, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2024) Vol. 1868, Iss. 3, pp. 130558-130558
Closed Access | Times Cited: 8
New Kids on the Block: RNA-Based Influenza Virus Vaccines
Francesco Berlanda Scorza, Norbert Pardi
Vaccines (2018) Vol. 6, Iss. 2, pp. 20-20
Open Access | Times Cited: 83
Recent Advances in RNA Therapeutics and RNA Delivery Systems Based on Nanoparticles
Hojeong Shin, S.D. Park, Yeajee Yim, et al.
Advanced Therapeutics (2018) Vol. 1, Iss. 7
Closed Access | Times Cited: 78
Expression Kinetics and Innate Immune Response after Electroporation and LNP-Mediated Delivery of a Self-Amplifying mRNA in the Skin
Hanne Huysmans, Zifu Zhong, Joyca De Temmerman, et al.
Molecular Therapy — Nucleic Acids (2019) Vol. 17, pp. 867-878
Open Access | Times Cited: 61
Influenza Vaccines: Successes and Continuing Challenges
Tanja Becker, Husni Elbahesh, Leslie A. Reperant, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. Supplement_4, pp. S405-S419
Open Access | Times Cited: 53
Considerations for bioanalytical characterization and batch release of COVID-19 vaccines
Gautam Sanyal, Anna Särnefält, Arun Kumar
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 45
Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologies
Gautam Sanyal
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 33
Advances in nanomedicine for the treatment of infectious diseases caused by viruses
Somya Ranjan Dash, Chanakya Nath Kundu
Biomaterials Science (2023) Vol. 11, Iss. 10, pp. 3431-3449
Closed Access | Times Cited: 19
mRNA vaccines: a new era in vaccine development
Shubhra Chandra, Jennifer C Wilson, David M. Good, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 10, pp. 1543-1564
Open Access | Times Cited: 7
Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine
Federico Perche, Rudy Clémençon, Kai Schulze, et al.
Molecular Therapy — Nucleic Acids (2019) Vol. 17, pp. 767-775
Open Access | Times Cited: 50
Delivery Approaches for Therapeutic Genome Editing and Challenges
Ilayda Ates, Tanner Rathbone, Callie Stuart, et al.
Genes (2020) Vol. 11, Iss. 10, pp. 1113-1113
Open Access | Times Cited: 49
Establishing Preferred Product Characterization for the Evaluation of RNA Vaccine Antigens
Cristina Poveda, Amadeo B. Biter, María Elena Bottazzi, et al.
Vaccines (2019) Vol. 7, Iss. 4, pp. 131-131
Open Access | Times Cited: 45
New Technologies for Influenza Vaccines
Steven Rockman, Karen L. Laurie, Simone Parkes, et al.
Microorganisms (2020) Vol. 8, Iss. 11, pp. 1745-1745
Open Access | Times Cited: 45
Investigating the Impact of Delivery System Design on the Efficacy of Self-Amplifying RNA Vaccines
Giulia Anderluzzi, Gustavo Lou, Simona Gallorini, et al.
Vaccines (2020) Vol. 8, Iss. 2, pp. 212-212
Open Access | Times Cited: 43
Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action
Giulietta Maruggi, Jeffrey B. Ulmer, Rino Rappuoli, et al.
Current topics in microbiology and immunology (2021), pp. 31-70
Closed Access | Times Cited: 34
The Development of mRNA Vaccines for Infectious Diseases: Recent Updates
Nitika Nitika, Wei Jiao, Ai‐Min Hui
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 5271-5285
Open Access | Times Cited: 34

Scroll to top